Teen Acne: Causes, Contributing Factors, and Treatment Pathways

Acne vulgaris affects ~85% of adolescents. It is a chronic inflammatory disease of the pilosebaceous unit driven by four interconnected factors:

Core Pathogenesis

  1. Androgen-driven sebum overproduction: Puberty surges (DHEA-S, testosterone) enlarge sebaceous glands and increase sebum.
  2. Follicular hyperkeratinization: Abnormal desquamation of keratinocytes forms a microcomedone (the precursor lesion).
  3. Cutibacterium acnes proliferation: Anaerobic bacterium thrives in sebum-rich, hypoxic follicles; triggers innate immunity via TLR2.
  4. Inflammation: C. acnes and follicular rupture release cytokines (IL-1, IL-12, TNF-α) → papules, pustules, nodules.

Modifying Factors

  • Genetics: Heritability ~80%; first-degree relative with severe acne ↑ risk 3–4×.
  • Diet: High-glycemic-load foods and dairy (especially skim milk) correlate with severity in some studies.
  • Stress: ↑ cortisol and androgens → flare-ups during exams, etc.
  • Mechanical: Occlusive helmets, tight collars, picking.
  • Medications: Corticosteroids, lithium, androgens, EGFR inhibitors.
  • Endocrine: PCOS, congenital adrenal hyperplasia, Cushing's.

Treatment Algorithm (Mild → Severe)

  • Mild (comedonal/few papules): Topical retinoid (adapalene 0.1%) ± benzoyl peroxide (BPO).
  • Moderate (inflammatory): Add topical antibiotic (clindamycin) or oral doxycycline/minocycline (limit 3–4 months).
  • Severe (nodulocystic, scarring): Oral isotretinoin (0.5–1 mg/kg/day × 16–24 weeks) — teratogenic; requires iPLEDGE.
  • Female hormonal: Combined OCP (estrogen + anti-androgenic progestin) or spironolactone.

Early effective treatment prevents scarring and psychosocial morbidity. Dermatology referral is appropriate for moderate-severe or treatment-resistant cases.

Teen Health - Related Articles